GGNNW:Genocea Biosciences Inc - Stock Price Quote and Dividend Data
GGNNW STOCK PRICE LATEST CLOSE
< $0.01
EXCHANGE
OTCBB
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Biotechnology
Genocea Biosciences Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
Genocea Biosciences Inc Stock Price Information
52-Week Low/High Stock Price$0.00 - $0.21
Percent Held by Institutions0.00%
Revenue$2,181,000
Net Income$-53,169,000
Cash Flow$-15,209,000
EPS-0.22%
Market Cap$0
PE Ratio to Industry40%
Debt-Equity Ratio61.74%
Debt-Equity to Industry1.24%
Total Return Last 12 Months-95.87%
Total Return Last 3 Years-99.86%
Total Return Last 5 Years0.00%
Latest Trade DateJun. 24, 2022
Genocea Biosciences Inc Annual Stock Dividends
No Data available for Payment History.
Genocea Biosciences Inc Dividend Payment History
| No dividends retrieved for GGNNW |
Genocea Biosciences Inc Other Dividend Details
Genocea Biosciences is a biopharmaceutical company that discovers and develops cancer immunotherapies using its ATLAS™ platform. The ATLAS platform profiles each patient's CD4+ and CD8+ T cell immune responses to every potential target or antigen identified by sequencing of that patient's tumor. Co.'s GEN-011 program is an adoptive T cell therapy using neoantigen-targeted peripheral cells (NPTs). The GEN-011 NPTs are specific for ATLAS identified anti-tumor antigens that are used to manufacture peripheral blood-derived, tumor-specific T cell therapy. Co.'s GEN-009 program is a neoantigen vaccine delivering adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Jun. 09, 2022GGNNW STOCK PRICE DECREASE: Genocea Biosciences Inc on 06-09-2022 decreased stock price > 10% from $0.01 to $0.00
Jun. 09, 2022GGNNW STOCK PRICE 52 WEEK LOW: Genocea Biosciences Inc on 06-09-2022 hit a 52 week low of $0.00
Jun. 07, 2022GGNNW STOCK PRICE INCREASE: Genocea Biosciences Inc on 06-07-2022 increased stock price > 10% from $0.00 to $0.01
May. 14, 2022GGNNW STOCK PRICE DECREASE: Genocea Biosciences Inc on 05-14-2022 decreased stock price > 10% from $0.01 to $0.00
May. 14, 2022GGNNW STOCK PRICE 52 WEEK LOW: Genocea Biosciences Inc on 05-14-2022 hit a 52 week low of $0.00
Apr. 19, 2022GGNNW STOCK PRICE DECREASE: Genocea Biosciences Inc on 04-19-2022 decreased stock price > 10% from $0.02 to $0.01
Mar. 25, 2022GGNNW STOCK PRICE INCREASE: Genocea Biosciences Inc on 03-25-2022 increased stock price > 10% from $0.01 to $0.02
Jan. 14, 2022GGNNW STOCK PRICE DECREASE: Genocea Biosciences Inc on 01-14-2022 decreased stock price > 10% from $0.04 to $0.01
Nov. 20, 2021GGNNW STOCK PRICE INCREASE: Genocea Biosciences Inc on 11-20-2021 increased stock price > 10% from $0.01 to $0.04
Nov. 09, 2021GGNNW STOCK PRICE DECREASE: Genocea Biosciences Inc on 11-09-2021 decreased stock price > 10% from $0.02 to $0.01
Apr. 11, 2025DIVIDEND RATE INCREASE: ADR (Sponsored)/CSL Ltd (OTCBB: CSLLY) on 04-11-2025 increased dividend rate > 3% from $1.22 to $1.28
Apr. 11, 2025KRBPQ STOCK PRICE DECREASE: Kiromic BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.12 to $0.08
Apr. 11, 2025OMGAQ STOCK PRICE DECREASE: Omega Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $0.05 to $0.04
Apr. 11, 2025ALGS STOCK PRICE DECREASE: Aligos Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $5.03 to $3.99
Apr. 11, 2025ATRA STOCK PRICE DECREASE: Atara Biotherapeutics Inc on 04-11-2025 decreased stock price > 10% from $5.89 to $5.30
Apr. 11, 2025ZVSA STOCK PRICE DECREASE: Com Par $0.001/ZyVersa Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $1.03 to $0.77
Apr. 11, 2025GERNW STOCK PRICE DECREASE: Wt Pur Com Exp 12/31/2025/Geron Corp. on 04-11-2025 decreased stock price > 10% from $0.30 to $0.27
Apr. 11, 2025RVMDW STOCK PRICE DECREASE: Wt Exp/Revolution Medicines Inc on 04-11-2025 decreased stock price > 10% from $0.05 to $0.03
Apr. 11, 2025ELUT STOCK PRICE DECREASE: Cl A Com/Elutia Inc on 04-11-2025 decreased stock price > 10% from $2.49 to $2.24
Apr. 11, 2025QNRX STOCK PRICE DECREASE: Sponsored ADR (New)/Quoin Pharmaceuticals Ltd on 04-11-2025 decreased stock price > 10% from $6.89 to $5.49
